Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Technetium-99m labeled agents for skeletal imaging

J H Thrall

    CRC Critical Reviews in Clinical Radiology and Nuclear Medicine
    |January 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Integrated diagnostics: proceedings from the 9th biennial symposium of the International Society for Strategic Studies in Radiology.

    European radiology·2012
    Same author

    Effect of multislice CT technology on scanner productivity.

    AJR. American journal of roentgenology·2001
    Same author

    Technical cost of CT examinations.

    Radiology·2001
    Same author

    Mass general provides case study in radiology asset management.

    Diagnostic imaging·2001
    Same author

    Utilization management remains elusive goal.

    Diagnostic imaging·2000
    Same author

    Cost of hospital-based radiological examinations: an update.

    European radiology·2000
    Same journal

    Manifestations of subdural and epidural hematomas on gamma imaging.

    CRC critical reviews in clinical radiology and nuclear medicine·1977
    Same journal

    Significant differences amont the 99mTc-polyphosphates, 99mTc-pyrophosphates, and 99mTc-diphosphonates for bone imaging.

    CRC critical reviews in clinical radiology and nuclear medicine·1977
    Same journal

    Essential knowledge about pitfalls in tomography.

    CRC critical reviews in clinical radiology and nuclear medicine·1976
    Same journal

    Transverse axial tomography of the spine.

    CRC critical reviews in clinical radiology and nuclear medicine·1976
    Same journal

    Antibiotic-associated pseudomembranous colitis.

    CRC critical reviews in clinical radiology and nuclear medicine·1976
    Same journal

    Ultrasonography in obstetrics and gynecology: historical notes, basic principles, safety considerations, and clinical applications.

    CRC critical reviews in clinical radiology and nuclear medicine·1976
    See all related articles

    Technetium-99m labeled radiopharmaceuticals revolutionized bone scanning. These agents, primarily diphosphonates, offer high labeling efficiency and sensitivity for detecting bone metastases and benign diseases.

    Area of Science:

    • Nuclear Medicine
    • Radiochemistry
    • Medical Imaging

    Background:

    • Technetium-99m (99mTc) radiopharmaceuticals are standard for skeletal imaging.
    • Their development in 1971 marked a significant advancement in bone scanning.
    • Early agents like polyphosphates have been largely replaced by pyrophosphate and diphosphonates.

    Purpose of the Study:

    • To review the development and application of 99mTc-labeled radiopharmaceuticals for skeletal imaging.
    • To discuss the chemistry, preparation, and quality control of these agents.
    • To highlight their diagnostic utility in detecting bone metastases and evaluating benign bone disease.

    Main Methods:

    • Review of literature on 99mTc-labeled phosphorus compounds for bone imaging.
    • Discussion of radiolabeling techniques involving Tin(II) reduction of Tc(VII).

    Related Experiment Videos

  • Analysis of in vivo distribution, kinetics, and clinical applications.

    • Main Results:

    • 99mTc-labeled diphosphonates offer high labeling efficiency (>95%) and are avid bone seekers.
    • Optimal molar ratios of phosphorus-compound to tin are crucial for labeling and biodistribution.
    • Potential contaminants like unreacted TcO4- require radiochemical quality control.
    • Skeletal uptake is significant (40-50% injected dose) within 2.5-4 hours post-injection.
    • 99mTc agents are more sensitive than radiographs or Fluorine-18 for detecting active bone lesions.

    Conclusions:

    • 99mTc-labeled radiopharmaceuticals, particularly diphosphonates, are essential for modern skeletal imaging.
    • These agents provide superior sensitivity for detecting metastatic bone disease compared to traditional methods.
    • Expanding applications in benign bone disease underscore their growing importance in nuclear medicine.